Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Shares Outstanding (Diluted Average) (2021 - 2025)

HeartSciences (HSCS) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 203.07% year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Oct 2025, up 203.07%, and an annual FY2025 reading of $938257.0, up 166.16% over the prior year.
  • Shares Outstanding (Diluted Average) was $2.8 million for Q4 2025 at HeartSciences, up from $1.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $7.4 million in Q1 2023 and bottomed at $79506.0 in Q2 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $2.3 million, with a median of $1.1 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Diluted Average) crashed 98.46% in 2023, then soared 760.79% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $3.3 million in 2021, then skyrocketed by 109.27% to $6.9 million in 2022, then plummeted by 98.46% to $106582.0 in 2023, then skyrocketed by 760.79% to $917445.0 in 2024, then soared by 203.07% to $2.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for HSCS at $2.8 million in Q4 2025, $1.3 million in Q3 2025, and $938257.0 in Q2 2025.